ML 1035

Known as: ML-1035 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1991-1993
01219911993

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
4-Amino-5-chloro-substituted benzamides have been shown to increase gastric motility in-vivo and enhance field-stimulated and… (More)
Is this relevant?
1994
1994
Methods are discussed which permit the calculation of the bioavailability (F) and fraction of an oral dose entering the central… (More)
Is this relevant?
1993
1993
ML-1035, 4-amino-5-chloro-2-[2-(methylsulfinyl)ethoxy]-N-[2- (diethyl-amino)ethyl]benzamide, is a sulfoxide compound and a… (More)
Is this relevant?
1993
1993
The pharmacokinetics of a new 5-hydroxytryptamine (5HT3) receptor antagonist, 4-amino-5-chloro-2-[(methylsulfinyl)ethoxy]-N-[2… (More)
Is this relevant?
1992
1992
The disposition of 4-amino-5-chloro-2-[2-(methylsulfinyl)ethoxy]-N- [2-(diethylamino)ethyl] benzamide hydrochloride (ML-1035… (More)
Is this relevant?
1992
1992
A fully automated column-switching HPLC procedure has been developed and validated for quantitation of ML-1035 and its five… (More)
Is this relevant?
1991
1991
ML-1035, is a gastroprokinetic agent structurally related to metoclopramide. Because ML-1035 contains an asymmetric chiral… (More)
Is this relevant?
1991
1991
Serotonin (5-HT) receptors in the myenteric plexus mediate contractility in vitro and may regulate gastric emptying in vivo. This… (More)
Is this relevant?